BSE filing, BSE: 544673. Summary written from the filing by ALFA Finder's alert engine.
Modern Diagnostic & Research Centre Ltd: key numbers
- Share price
- ₹58.00
- Market cap
- ₹87.58 Cr
- Revenue (annual)
- ₹83.11 Cr
- Net profit (annual)
- ₹5.25 Cr
- P/E (TTM)
- 16.7×Sector 52.8×
- Promoter holding
- 72.95%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Modern Diagnostic & Research Centre Ltd
All →Modern Diagnostic & Research Centre Other Announcement
The company submitted the Regulation 74(5) certificate for the half-year ended September 30, 2026, confirming depository participant compliance, alongside a nil investor grievance report.
Modern Diagnostic & Research Centre Annual General Meeting
Modern Diagnostic & Research Centre Limited conducted its 14th AGM on September 30, 2026. Shareholders transacted ordinary business, including the adoption of financial statements and auditor reappointment.
Modern Diagnostic & Research Centre Price Movement Clarification
Modern Diagnostic & Research Centre Ltd clarified its share price movement is purely market-driven. No undisclosed or price-sensitive information exists requiring disclosure under SEBI Regulations.
Modern Diagnostic & Research Centre Annual Report
Modern Diagnostic & Research Centre has submitted its Annual Report and Notice of the 14th Annual General Meeting for the financial year 2025-26.
Modern Diagnostic & Research Centre Annual General Meeting
Modern Diagnostic & Research Centre Limited has scheduled its 14th Annual General Meeting for September 30, 2026. The book closure is from September 24 to 30.
Modern Diagnostic & Research Centre Board Meeting Outcome
Modern Diagnostic & Research Centre approved various routine matters, including AGM notice, director reappointment, and statutory auditor reappointment. It also terminated a Jaipur laboratory management agreement.
Other board meeting date announcements
All →Capital India Finance Board Meeting Date
Capital India Finance will hold a board meeting on 6 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. The trading window stays closed until 48 hours after results are declared.
Laxmi Goldorna House Board Meeting Date
Laxmi Goldorna House Limited intimated a board meeting on 06 Nov 2026 to consider unaudited quarterly results for the period ended September 2026. The trading window is closed from 01 Oct 2026 until 48 hours after results.
Atma Industries Board Meeting Date
Atma Industries gave prior intimation of its 04 November 2026 board meeting to consider unaudited results for the quarter and half year ended 30 September 2026. The filing also notes the trading window closes from 01 October 2026.
Diana Tea Company Board Meeting Date
Diana Tea Company will hold a board meeting on 5 November 2026 to consider unaudited quarterly and half-yearly results for September 2026. The trading window stays closed from 1 October 2026 until 48 hours after the results are declared.
Cospower Engineering Board Meeting Date
CosPower Engineering will hold a board meeting on 4 November 2026 to consider half-year standalone results. The notice is advance intimation; agenda items are only proposed.
iSERA Lifesciences Board Meeting Date
iSERA Lifesciences gave notice of a board meeting on November 4, 2026 to consider standalone unaudited results for the quarter and half year ended September 30, 2026. The filing also notes the trading window closure from October 1, 2026.